Coronavirus disease-2019 (COVID-19) is known to cause pneumonia and adult respiratory distress syndrome (ARDS). It is found that it causes various microthrombosis and gives rise to vascular complications. To support this notion, we are presenting a case of acute myocardial infarction due to COVID-19 infection of a patient who does not have any symptoms of COVID-19 or coronary artery disease, ischemic heart disease, or any mico- or macrothrombosis in past.
A 60-year-old female patient presented to our hospital with complaints of chest pain radiating to the left shoulder and arm associated with sweating and palpitation. On detailed examination, her pulse rate was 100/minute, blood pressure (BP) was 140/90 mm Hg, her respiratory rate (RR) was 20/minute, and her oxygen saturation on her pulse oximeter is 98%. Electrocardiogram (ECG) done suggestive of acute myocardial infarction, that is, ST elevation in (V1–V4) precordial chest leads with reciprocal changes in limb leads. The patient is thrombosed with 15 lakhs units of streptokinase. She was started on heparin (unfractionated) infusion and loaded with antiplatelet drugs. Her X-ray chest showed features of COVID-19 pneumonitis. The patient's high-resolution computed tomography (HRCT) of the chest showed a severity score of 3/25.
Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 2020;127:104362. DOI: 10.1016/j.jcv.2020.104362.
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020;18(6):1421–1424. DOI: 10.1111/jth.14830.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145–147. DOI: 10.1016/j.thromres.2020.04.013.
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9–14. DOI: 10.1016/j.thromres.2020.04.024.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res 2020;191:148–150. DOI: 10.1016/j.thromres.2020.04.041.
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383(2):120–128. DOI: 10.1056/NEJMoa2015432.
Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, single-center, clinicopathologic case series. Ann Intern Med 2020;173(5):350–361. DOI: 10.7326/M20-2566.
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020;69(12):1181–1189. DOI: 10.1007/s00011-020-01401-6.
Helms J, Tacquard C, Severac F, Leonard–Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med 2020;46(6):1089–1098. DOI: 10.1007/s00134-020-06062-x.
Wahab SF, Løgstrup BB. Atypical manifestations of COVID-19 in general practice: A case of gastrointestinal symptoms. BMJ Case Rep 2020;13(8):e237520. DOI: 10.1136/bcr-2020-237520.
Falah NU, Hashmi S, Ahmed Z, Jaan A, Akhtar A, Khalid F, et al. Kawasaki disease-like features in 10 pediatric COVID-19 cases: A retrospective study. Cureus 2020;12(10):e11035. DOI: 10.7759/cureus.11035.